Article info

Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen

Authors

  1. Correspondence to Dr Irmela Mantel, Department of Ophthalmology, University Eye Hospital Jules Gonin, 15 Av. de France, Case postale 133, CH-1000 Lausanne 7, Switzerland; irmela.mantel{at}fa2.ch
View Full Text

Citation

Mantel I, Niderprim S, Gianniou C, et al
Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen

Publication history

  • Received October 30, 2013
  • Revised February 19, 2014
  • Accepted March 20, 2014
  • First published April 10, 2014.
Online issue publication 
August 18, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.